| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2009 | A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability | Liang, JJ; Liao, CL; Liao, JT; Lee, YL; Lin, YL. | Vaccine 27: 2746-2754 | | | |
| 2012 | Autophagy is involved in the early step of Japanese encephalitis virus infection | Li, JK; Liang, JJ; Liao, CL; Lin, YL. | Microbes and Infection 14, 159-168 | | | |
| 2021 | Convenient Auto-Processing Vector Based on Bamboo Mosaic Virus for Presentation of Antigens Through Enzymatic Coupling | Yang, MH; Hu, CC; Wong, CH; Liang, JJ; Ko, HY; He, MH; Lin, YL ; Lin, NS ; Hsu, YH | Frontiers in immunology 12, 739837 | | | |
| 2021 | Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir” | Chen, T; Fei, CY; Chen, YP; Sargsyan, K; Liang, JJ; Liao, CC ; Lin, YL ; Chang, CP; Yuan, HS ; Lim, C | ACS pharmacology & translational science 4(3), 1246 | | | |
| 2018 | DC-SIGN Binding Contributed by an Extra N-Linked Glycosylation on Japanese Encephalitis Virus Envelope Protein Reduces the Ability of Viral Brain Invasion. | Liang, JJ; Chou, MW; Lin, YL | Frontiers in Cellular and Infection Microbiology 8, 239 | | | |
| 2012 | Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2 | Li, PC; Liao, MY; Cheng, PC; Liang, JJ; Liu, IJ; Chiu, CY; Lin, YL; Chang, GJJ; Wu, HC | PLoS Neglected Tropical Diseases 6, e1636 | | | |
| 2023 | Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants | Sun, CP ; Chiu, CW; Wu, PY; Tsung, SI; Lee, IJ; Hu, CW; Hsu, MF; Kuo, TJ; Lan, YH; Chen, LY; Ng, HY; Chung, MJ; Liao, HN; Tseng, SC; Lo, CH; Chen, YJ; Liao, CC ; Chang, CS; Liang, JJ; Draczkowski, P; Puri, S; Chang, YC ; Huang, JS; Chen, CC; Kau, JH; Chen, YH ; Liu, WC ; Wu, HC ; Hsu, STD ; Wang, IH ; Tao, MH | Molecular Therapy 31(11), 3322-3336 | | | |
| 2018 | Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission. | Simanjuntak, Y; Liang, JJ; Chen, SY; Li, JK; Lee, YL; Wu, HC; Lin, YL | PLoS pathogens 14(2), e1006854 | | | |
| 2023 | Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission | Yang, CF; Liao, CC ; Hsu, HW; Liang, JJ; Chang, CS; Ko, HY; Chang, RH; Tang, WC; Chang, MH; Wang, IH ; Lin, YL | Journal of Biomedical Science 30(1), 87 | | | |
| 2010 | In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models | Lin, KH; Liang, JJ; Huang, WI; Lin-Chu, SY; Su, CY; Lee, YL; Jan, JT; Lin, YL; Cheng, YS; Wong, CH. | Antimicrobial Agents and Chemotherapy 54(10), 4129-4136 | | | |
| 2023 | Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan | Huang, YF; Hsu, FC; Wu, JJ; Lin, YL ; Liu, MT; Yang, CH; Kuo, HS; Chen, YJ; Cheng, CY; Lin, HH; Liao, CC ; Chang, CS; Liang, JJ; Cheng, WY; Huang, JC; Chen, CP; Cheng, SH; Lin, YC; Yang, SH; Chou, YJ | Journal of microbiology, immunology, and infection 56(3), 506-515 | | | |
| 2023 | Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin | Yang, CW; Hsu, HY; Lee, YZ; Jan, JT ; Chang, SY; Lin, YL ; Yang, RB ; Chao, TL; Liang, JJ; Lin, SJ; Liao, CC ; Chang, CS; Sytwu, HK; Hung, MS; Chen, CT; Lee, SJ | Biochemical pharmacology 215, 115688 | | | |
| 2018 | Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis. | Yang, CF; Gopula, B; Liang, JJ; Li, JK; Chen, SY; Lee, YL; Chen, CS; Lin, YL | Emerging microbes & infections 7(1), 187 | | | |
| 2019 | NS2B/NS3 mutations enhance the infectivity of genotype I Japanese encephalitis virus in amplifying hosts. | Fan, YC; Liang, JJ; Chen, JM; Lin, JW; Chen, YY; Su, KH; Lin, CC; Tu, WC; Chiou, MT; Ou, SC; Chang, GJ; Lin, YL ; Chiou, SS | PLoS pathogens 15(8), e1007992 | | | |
| 2021 | Potent anti-Delta effect by a booster third-dose of UB-612, a precision-designed SARS-CoV-2 multitope protein-peptide vaccine | Wang, CY; Hwang, KP; Kuo, HK; Peng, J; Shen, D; Kuo, B; Hou, KL; Cheng, J; Wang, MS; Yang, YT; Huang, JH; Chiu, HC; Jiang, MH; Shih, HY; Shen, HY; Chang, PY; Lan, YR; Chen, S; Liu, H; Ho, YH; Lin, F; Ding, S; Liu, Z; Wu, HT; Lin, YL ; Liang, JJ; Liao, CC; Chou, YC ; Morris, MK; Hanson, C; Guirakhoo, F; Hellerstein, M; Hu, MM; Yu, HJ; King, CCK; Heppner, D; Kemp, T; Monath, T. | Research Square | | | |
| 2021 | Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 | Hsu, HY; Yang, CW; Lee, YZ; Lin, YL ; Chang, SY; Yang, RB ; Liang, JJ; Chao, TL; Liao, CC ; Kao, HC; Wu, SH; Chang, JY; Sytwu, HK; Chen, CT; Lee, SJ | Frontiers in pharmacology 12, 706901 | | | |
| 2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | Hsieh, SM; Liu, MC; Chen, YH; Lee, WS; Hwang, SJ; Cheng, SH; Ko, WC; Hwang, KP; Wang, NC; Lee, YL; Lin, YL ; Shih, SR; Huang, CG; Liao, CC ; Liang, JJ; Chang, CS; Chen, C; Lien, CE; Tai, IC; Lin, TY | The Lancet. Respiratory medicine 9(12), 1396-1406 | | | |
| 2021 | Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants | Wang, HI; Chuang, ZS; Kao, YT; Lin, YL ; Liang, JJ; Liao, CC ; Liao, CL; Lai, MMC ; Yu, CY | International journal of molecular sciences 22(16), 9087 | | | |
| 2011 | Vimentin binding is critical for infection by the virulent strain of Japanese encephalitis virus | Liang, JJ; Yu, CY; Liao, CL; Lin, YL. | Cellular Microbiology 13, 1358-1370 | | | |
